Release of antibiotics from collagen dressing.
Our new collagen dressing has been developed recently. Three types (A, B, and C) of the dressing were prepared in this study. Each type contained bacitracin, neomycin or colistin. The antibiotic was input into: i. collagen sponge (CS)--type A, ii. layer of limited hydrophobicity (LLH)--type B, and iii. into both CS and LLH layers--type C. The final concentration of the antibiotic that resulted from the loading level was 2 mg/cm2 for the dressings of type A and B and 4 mg/cm2 for the dressing of type C. The antibiotics were then extracted from the pieces of dressings for two days through dialysis membrane. Susceptibility of 54 bacterial strains (S. aureus, P. aeruginosa, and Acinetobacter) isolated from burn wounds were tested to the three antibiotics used for preparation of the dressings. The results of the study evidenced that efficiency of released of antibiotics into the extracts depended on the kind of antibiotic and on the type of dressing. The concentration of the antibiotics proved to be much higher than MIC90 values of the bacterial isolates tested in respect to their susceptibility. The dressing containing mixture of the three antibiotics in two layers--CS and LLH is now considered as potentially effective for care of infected wounds. It may be useful for the treatment of infected wounds or for profilaxis of contaminated wounds, ensuring: i. sufficient antimicrobial activity in wound, and ii. optimal wound environment for the presence of collagenic biomaterial on the damaged tissue.
Grzybowski
J
J
Department of Microbiology, Military Institute of Hygiene and Epidemiology, Warsaw, Poland.
Antos-Bielska
M
M
Ołdak
E
E
Trafny
E A
EA
D000150:Acinetobacter / Q000187:drug effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000737:chemistry; D001414:Bacitracin / Q000008:administration & dosage* / Q000737:chemistry; D001684:Biological Dressings; D002056:Burns / Q000188:drug therapy / Q000382:microbiology; D003091:Colistin / Q000008:administration & dosage* / Q000737:chemistry; D003094:Collagen / Q000737:chemistry*; D004304:Dosage Forms; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009355:Neomycin / Q000008:administration & dosage* / Q000737:chemistry; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D004304:Dosage Forms; D001414:Bacitracin; D003094:Collagen; D009355:Neomycin; D003091:Colistin